{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T22:20:18Z","timestamp":1792880418731,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["496600"],"award-info":[{"award-number":["496600"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ijpharm.2016.09.057","type":"journal-article","created":{"date-parts":[[2016,9,20]],"date-time":"2016-09-20T00:46:28Z","timestamp":1474332388000},"page":"410-420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Lipid core peptide\/poly(lactic-co-glycolic acid) as a highly potent intranasal vaccine delivery system against Group A streptococcus"],"prefix":"10.1016","volume":"513","author":[{"given":"Nirmal","family":"Marasini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab G.","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwini Kumar","family":"Giddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khairunnisa Abdul","family":"Ghaffar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed M.","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Capon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Batzloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Good","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7257-807X","authenticated-orcid":false,"given":"Mariusz","family":"Skwarczynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istvan","family":"Toth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2016.09.057_bib0005","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1021\/jm701091d","article-title":"Structure-activity relationship of a series of synthetic lipopeptide self-adjuvanting group a streptococcal vaccine candidates","volume":"51","author":"Abdel-Aal","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpharm.2016.09.057_bib0010","doi-asserted-by":"crossref","first-page":"8041","DOI":"10.1021\/jm1007787","article-title":"Design of three-component vaccines against group A streptococcal infections: importance of spatial arrangement of vaccine components","volume":"53","author":"Abdel-Aal","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpharm.2016.09.057_bib0015","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/978-1-4939-3387-7_36","article-title":"The use of microwave-assisted solid-phase peptide synthesis and click chemistry for the synthesis of vaccine candidates against hookworm infection","volume":"1403","author":"Ahmad Fuaad","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ijpharm.2016.09.057_bib0020","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3390\/pharmaceutics5030392","article-title":"Adjuvant effect of Cationic liposomes for subunit influenza vaccine: influence of antigen loading method, cholesterol and immune modulators","volume":"5","author":"Barnier-Quer","year":"2013","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2016.09.057_bib0025","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1086\/466528","article-title":"Toward the development of an antidisease, transmission-blocking intranasal vaccine for group a streptococcus","volume":"192","author":"Batzloff","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpharm.2016.09.057_bib0030","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/74719","article-title":"New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population","volume":"6","author":"Brandt","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijpharm.2016.09.057_bib0035","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1023\/A:1011053931523","article-title":"The preparation, characterization, and evaluation of cationic microparticles for DNA vaccine delivery","volume":"18","author":"Briones","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2016.09.057_bib0040","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group A streptococcal diseases","volume":"5","author":"Carapetis","year":"2005","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijpharm.2016.09.057_bib0045","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.addr.2008.09.005","article-title":"Nanoparticles for nasal vaccination","volume":"61","author":"Csaba","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2016.09.057_bib0050","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","article-title":"PLGA-based nanoparticles: an overview of biomedical applications","volume":"161","author":"Danhier","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2016.09.057_bib0055","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijpharm.2005.03.035","article-title":"Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model","volume":"298","author":"Foged","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.09.057_bib0060","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.actbio.2016.04.012","article-title":"Liposome-based intranasal delivery of lipopeptide vaccine candidates against group a streptococcus","volume":"41","author":"Ghaffar","year":"2016","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijpharm.2016.09.057_bib0065","doi-asserted-by":"crossref","first-page":"19282","DOI":"10.1039\/C5NR06081H","article-title":"Stimulation of immune systems by conjugated olymers and their otential as an alternative vaccine adjuvant","volume":"7","author":"Gong","year":"2015","journal-title":"Nanoscale"},{"key":"10.1016\/j.ijpharm.2016.09.057_bib0070","doi-asserted-by":"crossref","DOI":"10.4161\/hv.25506","article-title":"Strategies in the development of vaccines to prevent infections with group A streptococcus","author":"Good","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.ijpharm.2016.09.057_bib0075","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fcimb.2013.00013","article-title":"Vaccine delivery using nanoparticles","volume":"3","author":"Gregory","year":"2013","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ijpharm.2016.09.057_bib0080","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1021\/bm500337r","article-title":"Antigen delivery by lipid-enveloped PLGA microparticle vaccines mediated by in situ vesicle shedding","volume":"15","author":"Hanson","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ijpharm.2016.09.057_bib0085","doi-asserted-by":"crossref","first-page":"11109","DOI":"10.1021\/acs.chemrev.5b00109","article-title":"Synthetic nanoparticles for vaccines and immunotherapy","volume":"115","author":"Irvine","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ijpharm.2016.09.057_bib0090","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1021\/nn5066793","article-title":"pH-responsive poly(d,l-lactic-co-glycolic acid) nanoparticles with rapid antigen release behavior promote immune response","volume":"9","author":"Liu","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijpharm.2016.09.057_bib0095","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jconrel.2016.01.050","article-title":"Immune responses to vaccines delivered by encapsulation into and\/or adsorption onto cationic lipid-PLGA hybrid nanoparticles","volume":"225","author":"Liu","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2016.09.057_bib0100","first-page":"279","article-title":"Analysis of peptide and lipopeptide content in liposomes","volume":"5","author":"Lutsiak","year":"2002","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.09.057_bib0105","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3251","article-title":"Recent progress in mucosal vaccine development: potential and limitations","volume":"12","author":"Lycke","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijpharm.2016.09.057_bib0110","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1479-5876-9-34","article-title":"Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy","volume":"9","author":"Ma","year":"2011","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ijpharm.2016.09.057_bib0115","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1586\/14760584.2014.936852","article-title":"Oral delivery of nanoparticle-based vaccines","volume":"13","author":"Marasini","year":"2014","journal-title":"Expert Rev. Vaccin."},{"key":"10.1016\/j.ijpharm.2016.09.057_bib0120","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.2217\/nnm.16.36","article-title":"Multilayer engineered nanoliposomes as a novel tool for oral delivery of lipopeptide-based vaccines against group A Streptococcus","volume":"11","author":"Marasini","year":"2016","journal-title":"Nanomed. (London)"},{"key":"10.1016\/j.ijpharm.2016.09.057_bib0125","doi-asserted-by":"crossref","first-page":"9037","DOI":"10.1128\/JVI.75.19.9037-9043.2001","article-title":"Induction of potent immune responses by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccines","volume":"75","author":"O'Hagan","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.ijpharm.2016.09.057_bib0130","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1586\/erv.10.89","article-title":"Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses","volume":"9","author":"Oyewumi","year":"2010","journal-title":"Expert Rev. Vaccin."},{"key":"10.1016\/j.ijpharm.2016.09.057_bib0135","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.2217\/nnm.14.156","article-title":"Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery","volume":"9","author":"Pavot","year":"2014","journal-title":"Nanomed. (London)"},{"key":"10.1016\/j.ijpharm.2016.09.057_bib0140","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/978-1-61779-151-2_18","article-title":"Lipid-core-peptide system for self-adjuvanting synthetic vaccine delivery","volume":"751","author":"Skwarczynski","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ijpharm.2016.09.057_bib0145","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.2217\/nnm.14.187","article-title":"Recent advances in peptide-based subunit nanovaccines","volume":"9","author":"Skwarczynski","year":"2014","journal-title":"Nanomed. (London)"},{"key":"10.1016\/j.ijpharm.2016.09.057_bib0150","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1039\/C5SC03892H","article-title":"Peptide-based synthetic vaccines","volume":"7","author":"Skwarczynski","year":"2016","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ijpharm.2016.09.057_bib0155","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jconrel.2009.05.011","article-title":"Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination","volume":"138","author":"Slutter","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2016.09.057_bib0160","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijpharm.2004.09.002","article-title":"PLA-PEG particles as nasal protein carriers: the influence of the particle size","volume":"292","author":"Vila","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.09.057_bib0165","doi-asserted-by":"crossref","first-page":"8515","DOI":"10.1021\/jm301074n","article-title":"Structure-activity relationship for the development of a self-adjuvanting mucosally active lipopeptide vaccine against Streptococcus pyogenes","volume":"55","author":"Zaman","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpharm.2016.09.057_bib0170","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.2217\/nnm.14.190","article-title":"Group A Streptococcal vaccine candidate: contribution of epitope to size, antigen presenting cell interaction and immunogenicity","volume":"9","author":"Zaman","year":"2014","journal-title":"Nanomed. (London)"},{"key":"10.1016\/j.ijpharm.2016.09.057_bib0175","doi-asserted-by":"crossref","first-page":"11751","DOI":"10.1073\/pnas.1304504110","article-title":"Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma","volume":"110","author":"Zhou","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316308870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316308870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:35:43Z","timestamp":1759916143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517316308870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":35,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0378517316308870"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.09.057","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid core peptide\/poly(lactic-co-glycolic acid) as a highly potent intranasal vaccine delivery system against Group A streptococcus","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.09.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}